Haoxi Health Technology Limited (HAO)

Haoxi Health Technology Income Statement

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	42.57	28.23	16.16	12.85
Revenue Growth (YoY)	137.58%	74.72%	25.76%	-
Cost of Revenue	40.04	26.17	15.51	12.24
Gross Profit	2.53	2.06	0.65	0.61
Selling, General & Admin	0.95	0.81	0.28	0.21
Research & Development	0.07	0.06	0.1	0.06
Operating Expenses	1.01	0.87	0.38	0.28
Operating Income	1.52	1.2	0.27	0.33
Interest Expense	-0.03	-0.02	-0.01	-0
Other Non Operating Income (Expenses)	0.01	0.01	-0	-0
Pretax Income	1.5	1.19	0.26	0.33
Income Tax Expense	0.22	0.22	0.02	0.02
Net Income	1.28	0.97	0.24	0.3
Net Income to Common	1.28	0.97	0.24	0.3
Net Income Growth	120.92%	296.49%	-19.56%	-
Shares Outstanding (Basic)	30	28	25	25
Shares Outstanding (Diluted)	30	28	25	25
Shares Change (YoY)	17.79%	10.45%	-	-
EPS (Basic)	0.04	0.04	0.01	0.01
EPS (Diluted)	0.04	0.04	0.01	0.01
EPS Growth	87.56%	258.97%	-19.56%	-
Free Cash Flow	-0.83	-0.92	-0.68	2.65
Free Cash Flow Per Share	-0.03	-0.03	-0.03	0.11
Gross Margin	5.95%	7.30%	4.02%	4.71%
Operating Margin	3.57%	4.24%	1.66%	2.57%
Profit Margin	3.01%	3.44%	1.51%	2.37%
Free Cash Flow Margin	-1.96%	-3.25%	-4.23%	20.59%
EBITDA	1.54	1.2	0.27	0.33
EBITDA Margin	3.62%	4.27%	1.68%	2.58%
D&A For EBITDA	0.02	0.01	0	0
EBIT	1.52	1.2	0.27	0.33
EBIT Margin	3.57%	4.24%	1.66%	2.57%
Effective Tax Rate	14.73%	18.54%	5.78%	6.52%

Source: S&P Capital IQ. Standard template.